27 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
to be finalized before the end of FY2022. Closing of the transaction is contingent on completion of review under antitrust laws, including the Hart-Scott … -Rodino (HSR) Antitrust Improvements Act of 1976.
Evercore Group LLC is acting as exclusive financial advisor to Takeda and Cleary Gottlieb Steen
6-K
TAK
Takeda Pharmaceutical Co
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
is contingent on completion of review under antitrust laws, including the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976.
1.Rationale
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:14am
below. ACTOS Antitrust Litigation In December 2013, the first of two antitrust class action lawsuits was filed against Takeda in the U.S. District … . INTUNIV Antitrust Litigation In January 2017, an antitrust class action was filed against Shire plc, Shire LLC, and Shire U.S. Inc. (collectively, “Shire
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
12:00am
to its products and its activities, the most significant of which are describe below. ACTOS Antitrust Litigation In December 2013, the first of two … antitrust class action lawsuits was filed against Takeda in the U.S. District Court for the Southern District of New York by a putative class of patients
SC TO-T
EX-99
pnml823teea7v1t8hxj
30 Apr 18
Third party tender offer statement
6:13am
6-K
jy17c9t
2 Feb 24
Current report (foreign)
6:16am
DRS/A
if5jntysxi90k
16 Nov 18
Draft registration statement (amended)
12:00am
6-K
EX-99.1
2yg0pyyh8v dqvb
28 May 21
Current report (foreign)
6:03am
6-K
wi90 zcb8cgsp04l
27 May 20
Current report (foreign)
6:05am
DRS/A
EX-99.1
lzkj5943zslk1 ey
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
EX-99.1
1ppl62 6j
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B/A
EX-99.1
vkbve
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
1qahg1b5ojxgjx
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
26s70l9w5sbq2515
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
6-K
bwmsh8ksmv5rmpdwb
5 Nov 21
Current report (foreign)
6:02am
SC TO-T
EX-99
m5fxf00bnf 5tbvah
30 Apr 18
Third party tender offer statement
6:13am
6-K
7nvj0
10 Feb 22
Current report (foreign)
6:03am